Antengene Corporation Limited

HK$2.82As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6996Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 6Y CAGR (25.39%)
Div yield —
ROE 6.39%
Biotechnology
Beta (5Y) 0.41
PE TTM 29.04
TSR TTM (45.56%)
Mkt cap HK$1.939B
ROIC 9.20%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.33
18.01%
(85.56%)
Hold 7|6|11|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.06
0.06
7.94%
16.90%
21.88%
22.72%
Revenue¥M
103.4
107.0
106.1
108.6
10.21%
11.13%
5.49%
4.46%
Peers (US$247.3M)
Cap (US$)
PE
249.9M
21.32x
Capital
TTM
5Y
10Y
Leveragex
0.079
(0.411)
(0.296)
EBIT/Intx
1.065
0.336
0.259
Own earn%
(9.23)
175.86
174.19
Sh yield%
30.07
33.53
30.56
Owners
Insiders/Inst%
9.10
41.07
Short interest%
2.43
SBC / revenue%
3.05
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
2–9
$1 testx
—
Incr. ROIC%
6